Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27

Oncogene volume 20, pages 4138–4149 (2001)Cite this article

Abstract

Many lines of evidence indicate that connexin genes expressing gap junction (GJ) proteins inhibit tumor cell proliferation. However, the precise molecular mechanisms remain unclear. In this study, we show that overexpression of connexin43 (Cx43) suppressed proliferation of human osteosarcoma U2OS cells through inhibition of the cell cycle transition from G1 to S phase. This inhibition was attributed to a significant accumulation of the hypophosphorylated retinoblastoma (Rb) protein, which was causally related to decreases in the kinase activities of cyclin-dependent kinases (CDKs) 2 and 4. Enforced Cx43 expression markedly increased the level of the CDK inhibitor p27. This increase resulted from an increased synthesis and a reduced degradation of the p27 proteins, but not influence of the p27 mRNA. Moreover, we show that the Cx43-modulated GJ function was the main contributor to the elevation in p27 levels, in which cAMP was involved. These data suggest that Cx43 appears to inhibit proliferation of U2OS cells by increasing the levels of p27 proteins via post-transcriptional regulatory mechanisms.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Bennett MVL, Barrio LC, Bargiello TA, Spray DC . 1991 Neuron 6: 305–320

  • Beyer EC, Paul DL, Goodenough DA . 1987 J. Cell Biol. 105: 2621–2629

  • Beyer EC . 1993 Int. Rev. Cytol. 137: 1–37

  • Boynton AL, Whitfield JF . 1983 Adv. Cycl. Nucl. Res. 15: 193–294

  • Bradshaw SL, Naus CCG, Zhu D, Kidder GM, Han VK . 1993 Growth Regul. 3: 26–29

  • Bruzzone R, White TW, Paul DL . 1996 Eur. J. Biochem. 238: 1–27

  • Chen SCD, Pelletier B, Ao P, Boynton AL . 1995 Cell Growth Differ. 6: 681–690

  • Cornil I, Theodorescu D, Man S, Herlyn M, Jambrosic J, Kerbel RS . 1991 Proc. Natl. Acad. Sci. USA 89: 6028–6032

  • Duflot-Dancer A, Mesnil M, Yamasaki H . 1997 Oncogene 15: 2151–2158

  • Dyson N . 1998 Genes Dev. 12: 2245–2262

  • Fitzgerald DJ, Yamasaki H . 1990 Teratog. Carcinog. Mutagen 10: 89–102

  • Goodenough DA, Goliger JA, Paul DL . 1996 Annu. Rev. Biochem. 65: 475–502

  • Grossel MJ, Baker GL, Hinds PW . 1999 J. Biol. Chem. 274: 29960–29967

  • Huang RP, Fan Y, Hossain MZ, Peng A, Zeng ZL, Boynton AL . 1998 Cancer Res. 58: 5089–5096

  • Kandel ER . 2000 Brain Res. Rev. 32: 3–5

  • Kato J, Matsuoka M, Polyak K, Massague J, Sherr CJ . 1994 Cell 79: 487–496

  • Koffler L, Roshong S, Park IK, Cesen-Cummings K, Thompson DC, Dwyer-Nield LD, Rice P, Mamay C, Malkinson AM, Ruch RJ . 2000 J. Cell. Biochem. 79: 347–354

  • Krutovskikh VA, Troyanovsky SM, Piccoli C, Tsuda H, Asamoto M, Yamasaki H . 2000 Oncogene 19: 505–513

  • Kumar NM, Gilula NB . 1996 Cell 84: 381–388

  • Loewenstein WR . 1979 Biochim. Biophys. Acta Cancer Rev. 560: 1–5

  • Martin W, Zempel G, Hulser D, Willecke K . 1991 Cancer Res. 51: 5348–5354

  • Martyn KD, Kurata WE, Warn-Cramer BJ, Burt JM, TenBroek E, Lau AF . 1997 Cell. Growth Differ. 8: 1015–1027

  • Mehta PP, Bertram JS, Loewenstein WR . 1986 Cell 44: 187–196

  • Mehta PP, Rotz-Wagenblatt A, Rose B, Shalloway D, Loewenstein WR . 1991 J. Mem. Biol. 124: 207–225

  • Mehta PP, Lokeshwar BL, Schiller PC, Bendix MV, Ostenson RC, Howard GA, Roos BA . 1996 Mol. Carcinog. 15: 18–32

  • Mesnil M, Krutovskikh VA, Piccoli C, Elfgang C, Traub O, Willecke K, Yamasaki H . 1995 Cancer Res. 55: 629–639

  • Omori Y, Yamasaki H . 1998 Int. J. Cancer 78: 446–453

  • Orford K, Orford CC, Byers SW . 1999 J. Cell Biol. 146: 855–867

  • Paul DL . 1995 Cur. Opin. Cell. Biol. 7: 665–672

  • Proulx AA, Lin ZX, Naus CCG . 1997 Cell Growth Differ. 8: 533–540

  • Rae RS, Mehta PP, Chang CC, Trosko JE, Ruch RJ . 1998 Mol. Carcinog. 22: 120–127

  • Sherr CJ . 1996 Science 274: 1672–1677

  • Sherr CJ, Roberts JM . 1999 Genes Dev. 13: 1501–1512

  • Statuto M, Audebet C, Tonoli H, Selmi-Ruby S, Rousset B, Munari-Silem Y . 1997 J. Biol. Chem. 272: 24710–24716

  • Temme A, Buchmann A, Gabriel HD, Nelles E, Schwarz M, Willecke K . 1997 Curr. Biol. 7: 713–716

  • Trosko JE, Madhukar BV, Chang CC . 1993 Life Sci. 53: 1–19

  • Weinberg RA . 1995 Cell 81: 323–330

  • Yamasaki H, Mesnil M, Omori Y, Mironor N, Krutovskikh V . 1995 Mutat. Res. 333: 181–188

  • Yamasaki H, Naus CCG . 1996 Carcinogenesis (Lond.) 17: 1199–1213

  • Yamasaki H, Krutovskikh V, Mesnil M, Tanaka T, Zaidan-Dagli ML, Omori Y . 1999 C.R. Acad. Sci. III 322: 151–159

  • Zhang YW, Morita I, Nishida M, Murota S . 1999a J. Cell. Physiol. 180: 305–313

  • Zhang YW, Morita I, Yao XS, Murota S . 1999b Prostaglandins Leukotr. Essen. Fatty Acids 61: 33–40

  • Zhang YW, Morita I, Gang S, Yao XS, Murota S . 2000a Planta Med. 66: 114–118

  • Zhang YW, Morita I, Zhang L, Gang S, Yao XS, Murota S . 2000b Planta Med. 66: 119–123

  • Zhu D, Kidder GM, Caveney S, Naus CCG . 1992 Proc. Natl. Acad. Sci. USA 89: 10218–10221

Download references

Author information

Authors and Affiliations

  1. Department of Cellular Physiological Chemistry, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8549, Japan

    You-Wei Zhang, Ikuo Morita & Seiitsu Murota

  2. Section of Molecular Embryology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8549, Japan

    Masaaki Ikeda & Kai-Wen Ma

Authors
  1. You-Wei Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ikuo Morita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masaaki Ikeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kai-Wen Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Seiitsu Murota
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ikuo Morita.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, YW., Morita, I., Ikeda, M. et al. Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27. Oncogene 20, 4138–4149 (2001). https://doi.org/10.1038/sj.onc.1204563

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204563

Keywords

This article is cited by

Search

Advanced search

Quick links